In vivo effects of romidepsin on T-cell activation, apoptosis and function in the BCN02 HIV-1 kick&kill clinical trial by Rosás-Umbert, M, Ruiz-Riol, M, Fernández, MA, Marszalek, M, Coll, P, Manzardo, C, Cedeño, S, Miró, JM, Clotet, B, Hanke, T, Moltó, J, Mothe, B, Brander, C, BCN02 study group

Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers by Rosás-Umbert, M, Llano, A, Bellido, R, Olvera, A, Ruiz-Riol, M, Rocafort, M, Fernández, M, Cobarsi, P, Crespo, M, Dorrell, L, Del Romero, J, Alcami, J, Paredes, R, Brander, C, Mothe, B

Therapeutic vaccination refocuses t-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study) by Mothe, B, Manzardo, C, Sanchez-Bernabeu, A, Coll, P, Morón-López, S, Puertas, MC, Rosas-Umbert, M, Cobarsi, P, Escrig, R, Perez-Alvarez, N, Ruiz, I, Rovira, C, Meulbroek, M, Crook, A, Borthwick, N, Wee, EG, Yang, H, Miró, JM, Dorrell, L, Clotet, B, Martinez-Picado, J, Brander, C, Hanke, T, BCN 01 study group

HIVconsv vaccines and romidepsin in early-treated HIV-1-infected individuals: Safety, immunogenicity and effect on the viral reservoir (Study BCN02) by Mothe, B, Rosás-Umbert, M, Coll, P, Manzardo, C, Puertas, MC, Morón-López, S, Llano, A, Miranda, C, Cedeño, S, López, M, Alarcón-Soto, Y, Gómez Melis, G, Langohr, K, Barriocanal, AM, Toro, J, Ruiz, I, Rovira, C, Carrillo, A, Meulbroek, M, Crook, A, Wee, EG, Miró, JM, Clotet, B, Valle, M, Martinez-Picado, J, Hanke, T, Brander, C, Moltó, J, BCN02 Study Investigators